Knight Therapeutics Inc. announces voting results from the Annual Meeting

Author's Avatar
May 12, 2022

MONTREAL, May 11, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD, Financial) ("Knight" or the "Corporation") a leading pan-American (ex-US) specialty pharmaceutical company, announced today the voting results from the Annual Meeting of the Shareholders held virtually in Montreal, Quebec ("Meeting").